(Total Views: 124)
Posted On: 09/07/2023 10:40:46 AM
Post# of 124738
$CBAY News Article - CymaBay's Seladelpar Achieves High Statistical Significance for the Primary and Key Secondary Endpoints in the Phase 3 RESPONSE Trial in Primary Biliary Cholangitis https://marketwirenews.com/news-releases/cyma...13690.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
